Some research on surveys done of Canadian patients who had the CCSVI procedure done via medical tourism. The data is primarily from 2010-2011 so it may be out of date with current standards. Still interesting.
Well, that casts Zamboni in a poor light. No one has gone there because everything he has done is research-oriented, not medical tourism.Curiously, none had gone to Italy – even though Zamboni and his proteges there have established busy venoplasty programs for MS patients.
From 80% to 90% of patients received only venoplasty without stenting, except those treated in Poland, where stents were placed in more than 40% of patients.
Because patients had to return to Poland to deal with complications of stents or loss of improvements? Again, a lot of the data is from 2010, the first year the procedure was available and a year when a lot of knowledge was yet to be gained on how to optimally do the procedure.Poland, where there were three clinics patients had used, stood out as having the most extensive record of follow-up care, with about 80% of patients reporting having received something in both post-procedural therapy and evaluation.
Go USA. The US providers entered the ring many months after some international providers did. The US providers entered at a time when prices were naturally coming down because of supply and demand.Costs did vary, and, again, the U.S. was in the low to middle range.
All but two of the 124 patients said it had been successful -- 79% reporting no complications and 19% saying it was "successful with some trouble."
And, rating their overall satisfaction on a scale of 1 (worst) to 10 (best), the median was 7, and three-quarters of respondents rated it 5 or higher.